Status:
UNKNOWN
GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions:
Acute Lymphoblastic Leukemia
Eligibility:
All Genders
16-60 years
Phase:
PHASE2
Brief Summary
The present study aims at verifying the state of the art in what this illness concerns and at organizing a centralized samples analysis.
Detailed Description
The present trial is a prospective multicentric GIMEMA study, in which adult ALL patients are extensively analyzed at diagnosis by a multiparametric approach including CC and molecular analysis for th...
Eligibility Criteria
Inclusion
- Patients aged 16-60
- Diagnosed with previously untreated T-ALL and B-ALL
Exclusion
- previously treated ALL patients
- L3 B-ALL
Key Trial Info
Start Date :
October 1 1996
Trial Type :
INTERVENTIONAL
End Date :
December 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00439920
Start Date
October 1 1996
End Date
December 1 2018
Last Update
October 23 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.